Sponsor pipeline

Princess Maxima Center for Pediatric Oncology clinical trial pipeline

Get alerts when Princess Maxima Center for Pediatric Oncology's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
2
Phase 1/2
7
Phase 2
1
Phase 3
2
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05327894 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or… Acute Lymphoblastic Leukemia Recruiting 2026-07-10
NCT05994690 CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de… Acute Myeloid Leukemia in Children Recruiting 2025-08-05
Phase 2
NCT06262438 CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+… Acute Myeloid Leukemia in Children Recruiting 2025-08-05
Phase 1/2
NCT07399821 An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma Neuroblastoma Recruiting 2026-02-10
NCT04925609 Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors Anaplastic Large Cell Lymphoma, ALK-Positive Recruiting 2025-12-05
NCT05658640 HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or… Acute Lymphoblastic Leukemia, in Relapse Recruiting 2025-09-16
NCT05745714 HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine… Acute Lymphoblastic Leukemia, in Relapse Recruiting 2025-09-16
NCT05751044 HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in… Acute Lymphoblastic Leukemia Recruiting 2025-09-16
NCT07175415 HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With… Acute Lymphoblastic Leukemia Not Yet Recruiting 2025-09-16
NCT07020260 The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced… Leukemia Not Yet Recruiting 2025-06-13
Phase 1
NCT07156435 Vyxeos® With Clofarabine for Pediatric AML Relapsed Pediatric AML Recruiting 2025-09-05
NCT06485947 Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma Neuroblastoma Recruiting 2025-07-08
Not specified
NCT05270096 International Leukemia Target Board Relapsed Hematologic Malignancy Recruiting 2026-01-09

Disease areas by active trials

Leukemia (10) · Acute Lymphoblastic Leukemia (ALL) (5) · Acute Myeloid Leukemia (AML) (3) · Non-Hodgkin Lymphoma (2)

Get alerts when Princess Maxima Center for Pediatric Oncology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free